GENCARO BUCINDOLOL HCL
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jan 2024)
What this means for you
This application is over — abandoned 15 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88960902
- Mark type
- Design + words
- Filed
- 11 Jun 2020
- Published for opposition
- 20 Oct 2020
- Abandoned
- 15 Jan 2024
- Attorney of record
- Andrea K. Shannon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations made in significant part of bucindolol hcl, for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields
Owner
- ARCA Biopharma, Inc., Westminster, CO, US
- ARCA Biopharma, Inc., Westminster, CO, US
Prosecution history
- 16 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jun 2023 — SOU EXTENSION 5 GRANTED
- 12 Jun 2023 — SOU EXTENSION 5 FILED
- 12 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2022 — SOU EXTENSION 4 GRANTED
- 15 Dec 2022 — SOU EXTENSION 4 FILED
- 15 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jun 2022 — SOU EXTENSION 3 GRANTED
- 15 Jun 2022 — SOU EXTENSION 3 FILED
- 15 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 29 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED